The munKNEE.com Pot Stock Index of the 25 pure-play* cannabis stocks that trade for more than US$1/share declined 2.9% on Thursday with only 3 of the constituents advancing, 22 declining (88%), and 2 of the 4 associated sector categories declining. The details are as follows:

1 constituent advanced by 5% or more namely:

• cbdMD (YCBD) +7.4% vs. -7.9% on Wednesday
  • Neptune (NEPT) advanced 4.2% vs. a decline of 1.1% on Wednesday 
  • Avicanna (AVCNF) advanced 3.5% on top of a 3.6% advance on Wednesday.

5  constituents declined by 5% or more, namely:

1. Columbia (CCHWF) -9.5% on top of a 0.8% decline on Wednesday
2. Medicine Man (SHWZ) -7.7% on top of a 5.8% decline on Wednesday 
3. Greenlane (GNLN) -7.4% on top of a 6.0% decline on Wednesday
4. Planet 13 (PLNHF) -7.3% on top of a 11.5% decline on Wednesday
5. Curaleaf (CURLF) -6.0% on top of a 4.2% decline on Wednesday

17 other constituents declined.

Further details regarding the equal-weighted munKNEE.com Pot Stock Index are as follows:

1. *The 25 pure-play constituents in the munKNEE.com PSI are just that, pure, deriving 100% of their revenue from the sale of cannabis or cannabis-related products.

• As such, unlike every marijuana ETF (see this TalkMarkets article) and every other cannabis tracking index (see this TalkMarkets article), the munKNEE.com PSI excludes "wanna-be" companies that generate little, if any, of their total revenue directly from the cannabis industry, to reflect the true health of the marijuana industry in the U.S. and Canada.
• As such, the munKNEE.com PSI excludes: GW Pharmaceuticals (GWPH), Abbvie, (ABBV), Arena Pharmaceuticals (ARNA), GrowGeneration (GRWG), Scotts Miracle-Gro (SMG), Innovative Industrial Properties REIT (IIPR), New Age Beverages (NBEV), Alcanna (LQSIF), Alkerna (KERN) and Village Farms (VFF).

2. The average market capitalization of the munKNEE.com PSI is US$963M.

3. In addition, the constituents operate in 4 categories based on their primary area of focus in the cannabis industry and the constituents within each category are identified below with how each of the categories did:

1. The Vertically Integrated (i.e. Seed-to-Sale) Category consists of 21 companies that grow, process, and sell cannabis and hemp flower and related products and it declined 0.2% on Thursday on top of a 2.6% decline on Wednesday.
   • the 7 constituents that are Canadian Licensed Producers (LPs) declined 2.0%, on average, on Thursday on top of a 1.1%   decline on Wednesday.
     • ACB; APHA; CGC; CRON; OGI; ROMJF and TLRY
   • the 12 constituents that are U.S. Multi-State Operators (MSOs) advanced 0.6%, on average, on Thursday compared to a 3.0% decline on Wednesday.
     • ACRGF; AYRSF; CCHWF; CRLBF; CURLF; GTBIF; JUSHF; PLNHF; SHWZ; TRSSF; TCNNF and HRVSF
   • the 2 constituents that are only involved in the seed-to-sale of CBD from hemp advanced 1.6%, on average, on Thursday compared to a decline of 7.6% on Wednesday.
     • CWBHF and YCBD
2. The Extraction Category consists of companies focused on the extraction of cannabis compounds and their infusion into consumer products and it advanced 1.6%, on average, on Thursday compared to a decline of 1.8% on Wednesday.
   • the 2 constituents in this category are NEPT and VLNCF
3. The Consumption Devices Category consists of companies focused on developing and selling personal consumption devices for cannabis consumers such as vape pens and inhalers. It declined 7.4% on Thursday compared to a 6.0% advance on Wednesday.
   • the 1 constituent in this category is GNLN
4. The Biotechnology Category consists of pharmaceutical companies marketing new drugs and products utilizing cannabinoids and the category advanced 3.5% on Thursday on top of +3.6% on Wednesday, +4.6% on Tuesday and +2.8% on Monday.
   • the 1 constituent in this category is AVCNF

Please express your views or questions regarding this article in the comment section below.